pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    ELI-002 2P
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • ELLIOTTS B
    ELLIOTTS B (SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE)
    no indication LUKARE MEDICAL LLC
  • ELTROMBOPAG
    ELTROMBOPAG
    no indication ZYDUS PHARMS
  • Phase 2
    ELU-42
← prev
page 81 of 231
next →
131
Pain89
Neurology1
Diabetic Foot Ulcers
Eluciderm Inc
  • ELURYNG
    ELURYNG (ETONOGESTREL AND ETHINYL ESTRADIOL)
    no indication AMNEAL
  • Phase 1
    ELVN-001
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)$ELVN Enliven Therapeutics, Inc.
  • Phase 2
    ELVN-002
    Human Epidermal Growth Factor Receptor 2 Positive Breast…$ELVN Enliven Therapeutics, Inc.
  • Preclinical
    EMD-101
    Neutropenia EmendoBio Inc
  • Preclinical
    EMD-202
    Retinitis Pigmentosa (Retinitis) EmendoBio Inc
  • EMROSI
    EMROSI (MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE)
    no indication JOURNEY
  • EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
    EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
    no indication CHARTWELL RX
  • Phase 2
    EN-374
    Chronic Granulomatous Disease Ensoma Inc
  • ENALAPRIL MALEATE ORAL SOLUTION
    ENALAPRIL MALEATE ORAL SOLUTION
    no indication ALKEM LABS LTD
  • Phase 2
    ENB-003
    Pancreatic Cancer ENB Therapeutics LLC
  • Phase 3
    ENB-106
    Diabetic Retinopathy Ennovabio
  • Phase 3
    ENERGIF-703
    Diabetic Foot Ulcers Energenesis Biomedical Co Ltd
  • Phase 1
    ENS-002
    Atopic Dermatitis (Atopic Eczema) Concerto Biosciences Inc
  • Phase 1
    ENV-308
    Obesity Enveda Biosciences Inc
  • Phase 1
    ENV-6946
    Inflammatory Bowel Disease Enveda Biosciences Inc
  • Phase 1
    EO-2002
    Corneal Edema Emmecell LLC
  • Phase 2
    EO-2463
    Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat… Enterome Bioscience SA
  • EOVIST
    EOVIST (GADOXETATE DISODIUM)
    no indication BAYER HLTHCARE
  • Preclinical
    EP-055
    Male Contraception Eppin Pharma Inc
  • Phase 2
    EPI-321
    Facioscapulohumeral Muscular Dystrophy (FSHD) Epicrispr Biotechnologies Inc
  • EPIOXA CROSS-LINKING
    EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)
    no indication GLAUKOS
  • Preclinical
    EPM-301
    Prader-Willi Syndrome (PWS) EPM Group Inc
  • Preclinical
    EPS-401
    Non-Small Cell Lung Cancer Epsilogen Ltd
  • Preclinical
    EPV-002
    Substance (Drug) Abuse EpiVario Inc
  • EQUATE OMEPRAZOLE AND SODIUM BICARBONATE
    EQUATE OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE)
    no indication PERRIGO R AND D
  • Phase 1
    ER-100
    Non-Arteritic Anterior Ischemic Optic Neuropathy Life Biosciences Inc.